_MEMBER_Ccdc115,_LogP_Ccdc115,GO,_PATTERN_,_RANK_,GiniIndex,Category,CategoryID,Description,PARENT_GO,LogP,Enrichment,Z-score,#TotalGeneInLibrary,#GeneInGO,#GeneInHitList,#GeneInGOAndHitList,%InGO,STDV %InGO,GeneID,Hits,Log(q-value),EvidenceCutoff
1,-5.9,C0039590,M1,1,0,DisGeNET,35,Testicular Neoplasms,,-5.9,13,8.7,30286,124,134,7,5.2,1.9,367|2263|2321|4869|10973|27306|57515,AR|FGFR2|FLT1|NPM1|ASCC3|HPGDS|SERINC1,-2.1,0
1,-5.6,C0023267,M1,1,0,DisGeNET,35,Fibroid Tumor,,-5.6,6,6.8,30286,413,134,11,8.2,2.4,52|71|285|367|2246|3151|5354|7010|26136|27306|27328,ACP1|ACTG1|ANGPT2|AR|FGF1|HMGN2|PLP1|TEK|TES|HPGDS|PCDH11X,-2,0
1,-5.5,C0234985,M1,1,0,DisGeNET,35,Mental deterioration,,-5.5,5.3,6.6,30286,508,134,12,9,2.5,71|285|2321|3769|4747|7010|7534|8633|9122|10846|29978|388015,ACTG1|ANGPT2|FLT1|KCNJ13|NEFL|TEK|YWHAZ|UNC5C|SLC16A4|PDE10A|UBQLN2|RTL1,-2,0
1,-5,C3811918,M1,1,0,DisGeNET,35,GRN-related frontotemporal dementia,,-5,12,7.9,30286,112,134,6,4.5,1.8,4747|5094|29978|93986|220988|347240,NEFL|PCBP2|UBQLN2|FOXP2|HNRNPA3|KIF24,-1.5,0
1,-4.9,C1704436,M1,1,0,DisGeNET,35,Peripheral Arterial Diseases,,-4.9,6.4,6.4,30286,319,134,9,6.7,2.2,285|367|2246|2321|4907|7010|23452|57142|64805,ANGPT2|AR|FGF1|FLT1|NT5E|TEK|ANGPTL2|RTN4|P2RY12,-1.5,0
1,-4.6,C0751072,M1,1,0,DisGeNET,35,Frontotemporal Lobar Degeneration,,-4.6,8.1,6.6,30286,195,134,7,5.2,1.9,4747|4869|5094|29978|93986|220988|347240,NEFL|NPM1|PCBP2|UBQLN2|FOXP2|HNRNPA3|KIF24,-1.2,0
1,-4.5,C0231341,M1,1,0,DisGeNET,35,Premature aging syndrome,,-4.5,10,7,30286,136,134,6,4.5,1.8,367|443|1540|2246|23452|27429,AR|ASPA|CYLD|FGF1|ANGPTL2|HTRA2,-1.2,0
1,-4.1,C4721579,M1,1,0,DisGeNET,35,Secondary malignant neoplasm of colon and/or rectum,,-4.1,5.1,5.5,30286,397,134,9,6.7,2.2,52|71|285|2321|4907|7010|7150|26136|27306,ACP1|ACTG1|ANGPT2|FLT1|NT5E|TEK|TOP1|TES|HPGDS,-0.92,0
1,-4.1,C0393571,M1,1,0,DisGeNET,35,Multiple System Atrophy,,-4.1,36,10,30286,19,134,3,2.2,1.3,4747|7314|7529,NEFL|UBB|YWHAB,-0.9,0
1,-4.1,C0152171,M1,1,0,DisGeNET,35,Idiopathic pulmonary hypertension,,-4.1,8.4,6.3,30286,161,134,6,4.5,1.8,367|658|2263|2321|3357|7529,AR|BMPR1B|FGFR2|FLT1|HTR2B|YWHAB,-0.89,0
1,-4,C1145670,M1,1,0,DisGeNET,35,Respiratory Failure,,-4,5.7,5.6,30286,319,134,8,6,2,2246|3567|4988|4998|5000|9963|27429|29978,FGF1|IL5|OPRM1|ORC1|ORC4|SLC23A1|HTRA2|UBQLN2,-0.89,0
1,-4,C0018790,M1,1,0,DisGeNET,35,Cardiac Arrest,,-4,5,5.4,30286,410,134,9,6.7,2.2,285|367|808|4747|4907|7010|7534|27306|27329,ANGPT2|AR|CALM3|NEFL|NT5E|TEK|YWHAZ|HPGDS|ANGPTL3,-0.89,0
1,-4,C1876214,M1,1,0,DisGeNET,35,"ALBINOIDISM, OCULOCUTANEOUS, AUTOSOMAL DOMINANT",,-4,17,7.7,30286,54,134,4,3,1.5,7337|23682|283652|388015,UBE3A|RAB38|SLC24A5|RTL1,-0.89,0
1,-4,C0432103,M1,1,0,DisGeNET,35,Submucous cleft of hard palate,,-4,16,7.6,30286,55,134,4,3,1.5,4998|5000|7314|93986,ORC1|ORC4|UBB|FOXP2,-0.87,0
1,-3.9,C0042571,M1,1,0,DisGeNET,35,Vertigo,,-3.9,7.8,6,30286,173,134,6,4.5,1.8,808|3769|4869|4907|4988|26136,CALM3|KCNJ13|NPM1|NT5E|OPRM1|TES,-0.81,0
1,-3.9,C0018681,M1,1,0,DisGeNET,35,Headache,,-3.9,5.3,5.4,30286,338,134,8,6,2,367|808|2263|2321|3567|4988|9122|27306,AR|CALM3|FGFR2|FLT1|IL5|OPRM1|SLC16A4|HPGDS,-0.79,0
1,-3.8,C0240310,M1,1,0,DisGeNET,35,Hypoplasia of the maxilla,,-3.8,10,6.4,30286,113,134,5,3.7,1.6,2263|4998|5000|7314|7337,FGFR2|ORC1|ORC4|UBB|UBE3A,-0.78,0
1,-3.8,C0027796,M1,1,0,DisGeNET,35,Neuralgia,,-3.8,3.5,4.7,30286,766,134,12,9,2.5,285|2246|2857|3357|4747|4988|5354|5734|7534|23767|64805|388015,ANGPT2|FGF1|GPR34|HTR2B|NEFL|OPRM1|PLP1|PTGER4|YWHAZ|FLRT3|P2RY12|RTL1,-0.77,0
1,-3.7,C0012833,M1,1,0,DisGeNET,35,Dizziness,,-3.7,14,7,30286,64,134,4,3,1.5,3769|4907|4988|26136,KCNJ13|NT5E|OPRM1|TES,-0.72,0
1,-3.7,C0020452,M1,1,0,DisGeNET,35,Hyperemia,,-3.7,14,7,30286,64,134,4,3,1.5,285|4907|7010|64805,ANGPT2|NT5E|TEK|P2RY12,-0.72,0
1,-3.7,C0025500,M1,1,0,DisGeNET,35,Mesothelioma,,-3.7,4,4.8,30286,559,134,10,7.5,2.3,285|808|2246|2263|2321|4067|4907|7010|23741|27306,ANGPT2|CALM3|FGF1|FGFR2|FLT1|LYN|NT5E|TEK|EID1|HPGDS,-0.71,0
1,-3.7,C0004936,M1,1,0,DisGeNET,35,Mental disorders,,-3.7,3.4,4.6,30286,789,134,12,9,2.5,52|71|367|808|2263|2823|4747|4988|10846|27306|55840|93986,ACP1|ACTG1|AR|CALM3|FGFR2|GPM6A|NEFL|OPRM1|PDE10A|HPGDS|EAF2|FOXP2,-0.71,0
1,-3.6,C0042133,M1,1,0,DisGeNET,35,Uterine Fibroids,,-3.6,4,4.8,30286,569,134,10,7.5,2.3,52|71|285|367|3151|5354|26136|27306|27328|57142,ACP1|ACTG1|ANGPT2|AR|HMGN2|PLP1|TES|HPGDS|PCDH11X|RTN4,-0.68,0
1,-3.6,C0279628,M1,1,0,DisGeNET,35,Adenocarcinoma Of Esophagus,,-3.6,4.4,4.9,30286,467,134,9,6.7,2.2,367|443|1540|2246|2321|5734|7534|9122|27306,AR|ASPA|CYLD|FGF1|FLT1|PTGER4|YWHAZ|SLC16A4|HPGDS,-0.68,0
1,-3.6,C0007785,M1,1,0,DisGeNET,35,Cerebral Infarction,,-3.6,3.6,4.6,30286,687,134,11,8.2,2.4,285|2321|4988|6613|7010|7534|9068|27306|27429|57142|64805,ANGPT2|FLT1|OPRM1|SUMO2|TEK|YWHAZ|ANGPTL1|HPGDS|HTRA2|RTN4|P2RY12,-0.68,0
1,-3.6,C2919945,M1,1,0,DisGeNET,35,Cavernous Hemangioma of Brain,,-3.6,8.9,5.9,30286,127,134,5,3.7,1.6,285|808|2321|6019|7010,ANGPT2|CALM3|FLT1|RLN2|TEK,-0.67,0
1,-3.6,C0349204,M1,1,0,DisGeNET,35,Nonorganic psychosis,,-3.6,4.8,5,30286,376,134,8,6,2,71|212|2263|4988|7337|10846|27328|347730,ACTG1|ALAS2|FGFR2|OPRM1|UBE3A|PDE10A|PCDH11X|LRRTM1,-0.65,0
1,-3.5,C0014588,M1,1,0,DisGeNET,35,Epispadias,,-3.5,23,7.9,30286,30,134,3,2.2,1.3,367|4998|5000,AR|ORC1|ORC4,-0.61,0
1,-3.5,C0024408,M1,1,0,DisGeNET,35,Machado-Joseph Disease,,-3.5,8.4,5.7,30286,135,134,5,3.7,1.6,52|367|4747|7314|29978,ACP1|AR|NEFL|UBB|UBQLN2,-0.58,0
1,-3.4,C0236642,M1,1,0,DisGeNET,35,Pick Disease of the Brain,,-3.4,6.4,5.2,30286,213,134,6,4.5,1.8,4747|5094|7314|27306|29978|93986,NEFL|PCBP2|UBB|HPGDS|UBQLN2|FOXP2,-0.55,0
1,-3.4,C0041316,M1,1,0,DisGeNET,35,Lymph Node Tuberculosis,,-3.4,21,7.5,30286,33,134,3,2.2,1.3,285|3567|7010,ANGPT2|IL5|TEK,-0.54,0
1,-3.4,C0206734,M1,1,0,DisGeNET,35,Hemangioblastoma,,-3.4,11,6.2,30286,79,134,4,3,1.5,285|2246|2321|7010,ANGPT2|FGF1|FLT1|TEK,-0.54,0
1,-3.4,C0220641,M1,1,0,DisGeNET,35,Lip and Oral Cavity Carcinoma,,-3.4,3.4,4.4,30286,734,134,11,8.2,2.4,367|2321|4869|4988|5094|7534|9122|11259|23452|27306|27329,AR|FLT1|NPM1|OPRM1|PCBP2|YWHAZ|SLC16A4|FILIP1L|ANGPTL2|HPGDS|ANGPTL3,-0.54,0
1,-3.3,C0566899,M1,1,0,DisGeNET,35,Small labia majora,,-3.3,19,7.3,30286,35,134,3,2.2,1.3,2263|4998|5000,FGFR2|ORC1|ORC4,-0.5,0
1,-3.3,C0153381,M1,1,0,DisGeNET,35,Malignant neoplasm of mouth,,-3.3,3.3,4.2,30286,756,134,11,8.2,2.4,367|2321|4869|4988|5094|7534|9122|11259|23452|27306|27329,AR|FLT1|NPM1|OPRM1|PCBP2|YWHAZ|SLC16A4|FILIP1L|ANGPTL2|HPGDS|ANGPTL3,-0.47,0
1,-3.2,C0265950,M1,1,0,DisGeNET,35,Venous malformation,,-3.2,18,6.9,30286,38,134,3,2.2,1.3,285|367|7010,ANGPT2|AR|TEK,-0.44,0
1,-3.2,C0266013,M1,1,0,DisGeNET,35,Congenital hypoplasia of breast,,-3.2,18,6.9,30286,38,134,3,2.2,1.3,4998|5000|23767,ORC1|ORC4|FLRT3,-0.44,0
1,-3.2,C0014553,M1,1,0,DisGeNET,35,Absence Epilepsy,,-3.2,10,5.8,30286,88,134,4,3,1.5,3326|4988|7337|7534,HSP90AB1|OPRM1|UBE3A|YWHAZ,-0.44,0
1,-3.2,C0700636,M1,1,0,DisGeNET,35,Focal nodular hyperplasia of liver,,-3.2,17,6.8,30286,39,134,3,2.2,1.3,285|367|7010,ANGPT2|AR|TEK,-0.44,0
1,-3.2,C2937220,M1,1,0,DisGeNET,35,Congenital abnormality of vein,,-3.2,17,6.8,30286,39,134,3,2.2,1.3,285|367|7010,ANGPT2|AR|TEK,-0.44,0
1,-3.2,C3711376,M1,1,0,DisGeNET,35,Isodicentric Chromosome 15 Syndrome,,-3.2,17,6.8,30286,39,134,3,2.2,1.3,5354|7337|388015,PLP1|UBE3A|RTL1,-0.44,0
1,-3.1,C3811653,M1,1,0,DisGeNET,35,Experimental Organism Basal Cell Carcinoma,,-3.1,4.1,4.4,30286,437,134,8,6,2,367|1540|2263|2321|4907|7010|27306|128344,AR|CYLD|FGFR2|FLT1|NT5E|TEK|HPGDS|CIMAP3,-0.43,0
1,-3.1,C0730285,M1,1,0,DisGeNET,35,Diabetic macular edema,,-3.1,9.8,5.7,30286,92,134,4,3,1.5,285|2321|3567|7010,ANGPT2|FLT1|IL5|TEK,-0.43,0
1,-3.1,C0004606,M1,1,0,DisGeNET,35,Nonproliferative diabetic retinopathy,,-3.1,17,6.6,30286,41,134,3,2.2,1.3,285|2246|27329,ANGPT2|FGF1|ANGPTL3,-0.43,0
1,-3.1,C1292779,M1,1,0,DisGeNET,35,Myelodysplastic Syndrome with Isolated del(5q),,-3.1,17,6.6,30286,41,134,3,2.2,1.3,2246|3567|4869,FGF1|IL5|NPM1,-0.43,0
1,-3.1,C0007140,M1,1,0,DisGeNET,35,Carcinosarcoma,,-3.1,9.6,5.6,30286,94,134,4,3,1.5,285|367|2263|7150,ANGPT2|AR|FGFR2|TOP1,-0.43,0
1,-3.1,C0030499,M1,1,0,DisGeNET,35,Parasitic Diseases,,-3.1,6.9,5,30286,164,134,5,3.7,1.6,52|3567|7150|27306|51714,ACP1|IL5|TOP1|HPGDS|SELENOT,-0.43,0
1,-3.1,C0158266,M1,1,0,DisGeNET,35,Intervertebral Disc Degeneration,,-3.1,4.6,4.5,30286,342,134,7,5.2,1.9,285|367|6613|7529|7534|10209|203547,ANGPT2|AR|SUMO2|YWHAB|YWHAZ|EIF1|VMA21,-0.43,0
1,-3.1,C1802398,M1,1,0,DisGeNET,35,"Chromosome 5, trisomy 5q",,-3.1,16,6.5,30286,42,134,3,2.2,1.3,2246|3567|4869,FGF1|IL5|NPM1,-0.43,0
1,-3,C0033975,M1,1,0,DisGeNET,35,Psychotic Disorders,,-3,3.6,4.2,30286,560,134,9,6.7,2.2,71|212|2263|4988|7337|10846|27306|27328|347730,ACTG1|ALAS2|FGFR2|OPRM1|UBE3A|PDE10A|HPGDS|PCDH11X|LRRTM1,-0.42,0
1,-3,C4551488,M1,1,0,DisGeNET,35,Bifid uvula,,-3,9.3,5.5,30286,97,134,4,3,1.5,2263|4998|5000|7314,FGFR2|ORC1|ORC4|UBB,-0.41,0
1,-3,C0024530,M1,1,0,DisGeNET,35,Malaria,,-3,3.3,4.1,30286,683,134,10,7.5,2.3,52|71|285|443|2321|3567|4998|5354|10758|27306,ACP1|ACTG1|ANGPT2|ASPA|FLT1|IL5|ORC1|PLP1|TRAF3IP2|HPGDS,-0.41,0
1,-3,C0235946,M1,1,0,DisGeNET,35,Cerebral atrophy,,-3,4,4.3,30286,454,134,8,6,2,443|2246|4747|5354|27306|27429|57531|124512,ASPA|FGF1|NEFL|PLP1|HPGDS|HTRA2|HACE1|METTL23,-0.41,0
1,-3,C1866190,M1,1,0,DisGeNET,35,Atresia of the external auditory canal,,-3,15,6.4,30286,44,134,3,2.2,1.3,2263|4998|5000,FGFR2|ORC1|ORC4,-0.41,0
1,-3,C1845977,M1,1,0,DisGeNET,35,X- linked recessive,,-3,6.6,4.9,30286,172,134,5,3.7,1.6,212|367|5354|91851|203547,ALAS2|AR|PLP1|CHRDL1|VMA21,-0.4,0
1,-3,C0004045,M1,1,0,DisGeNET,35,Asphyxia Neonatorum,,-3,15,6.3,30286,45,134,3,2.2,1.3,2321|4747|27429,FLT1|NEFL|HTRA2,-0.4,0
1,-3,C0740302,M1,1,0,DisGeNET,35,5q-syndrome,,-3,15,6.3,30286,45,134,3,2.2,1.3,2246|3567|4869,FGF1|IL5|NPM1,-0.4,0
1,-3,C2931852,M1,1,0,DisGeNET,35,Clear-cell metastatic renal cell carcinoma,,-3,5.2,4.6,30286,260,134,6,4.5,1.8,226|285|367|4907|7010|8633,ALDOA|ANGPT2|AR|NT5E|TEK|UNC5C,-0.39,0
1,-3,C0686377,M1,1,0,DisGeNET,35,CNS metastases,,-3,8.9,5.3,30286,102,134,4,3,1.5,367|443|4907|388015,AR|ASPA|NT5E|RTL1,-0.39,0
1,-3,C0344530,M1,1,0,DisGeNET,35,Congenital keratoglobus,,-3,15,6.2,30286,46,134,3,2.2,1.3,2263|7010|91851,FGFR2|TEK|CHRDL1,-0.39,0
1,-2.9,C3469521,M1,1,0,DisGeNET,35,"FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)",,-2.9,4.4,4.3,30286,359,134,7,5.2,1.9,52|367|4809|4869|4988|7150|27306,ACP1|AR|SNU13|NPM1|OPRM1|TOP1|HPGDS,-0.39,0
1,-2.9,C0027708,M1,1,0,DisGeNET,35,Nephroblastoma,,-2.9,3.5,4,30286,586,134,9,6.7,2.2,367|2742|4747|4869|26136|27306|27429|29119|57531,AR|GLRA2|NEFL|NPM1|TES|HPGDS|HTRA2|CTNNA3|HACE1,-0.36,0
1,-2.9,C1292778,M1,1,0,DisGeNET,35,Chronic myeloproliferative disorder,,-2.9,4.3,4.3,30286,366,134,7,5.2,1.9,367|4067|4869|4998|5000|7010|64805,AR|LYN|NPM1|ORC1|ORC4|TEK|P2RY12,-0.36,0
1,-2.9,C0026703,M1,1,0,DisGeNET,35,Mucopolysaccharidoses,,-2.9,14,6.1,30286,48,134,3,2.2,1.3,212|1540|4907,ALAS2|CYLD|NT5E,-0.36,0
1,-2.9,C0221765,M1,1,0,DisGeNET,35,Chronic schizophrenia,,-2.9,14,6.1,30286,48,134,3,2.2,1.3,808|57142|93986,CALM3|RTN4|FOXP2,-0.36,0
1,-2.9,C4551584,M1,1,0,DisGeNET,35,Brain atrophy,,-2.9,6.2,4.7,30286,182,134,5,3.7,1.6,443|2246|4747|5354|27306,ASPA|FGF1|NEFL|PLP1|HPGDS,-0.36,0
1,-2.9,C0856169,M1,1,0,DisGeNET,35,Endothelial dysfunction,,-2.9,3.2,3.9,30286,716,134,10,7.5,2.3,285|808|2321|4907|6019|6613|9122|10758|23452|64805,ANGPT2|CALM3|FLT1|NT5E|RLN2|SUMO2|SLC16A4|TRAF3IP2|ANGPTL2|P2RY12,-0.36,0
1,-2.9,C0346153,M1,1,0,DisGeNET,35,"Breast Cancer, Familial",,-2.9,6.2,4.7,30286,183,134,5,3.7,1.6,285|367|2263|7010|27306,ANGPT2|AR|FGFR2|TEK|HPGDS,-0.36,0
1,-2.9,C0155877,M1,1,0,DisGeNET,35,Allergic asthma,,-2.9,4.3,4.2,30286,371,134,7,5.2,1.9,3567|4907|7534|8528|10803|26136|27306,IL5|NT5E|YWHAZ|DDO|CCR9|TES|HPGDS,-0.36,0
1,-2.9,C0242994,M1,1,0,DisGeNET,35,Hantavirus Infections,,-2.9,8.4,5.1,30286,108,134,4,3,1.5,285|7010|64805|283652,ANGPT2|TEK|P2RY12|SLC24A5,-0.36,0
1,-2.8,C0085084,M1,1,0,DisGeNET,35,Motor Neuron Disease,,-2.8,6.1,4.6,30286,186,134,5,3.7,1.6,367|4747|4907|29978|220988,AR|NEFL|NT5E|UBQLN2|HNRNPA3,-0.34,0
1,-2.8,C0041948,M1,1,0,DisGeNET,35,Uremia,,-2.8,8.2,5.1,30286,110,134,4,3,1.5,285|2321|3184|7010,ANGPT2|FLT1|HNRNPD|TEK,-0.34,0
1,-2.8,C0010278,M1,1,0,DisGeNET,35,Craniosynostosis,,-2.8,3.7,4,30286,488,134,8,6,2,808|2263|3567|4907|4998|5000|5734|27306,CALM3|FGFR2|IL5|NT5E|ORC1|ORC4|PTGER4|HPGDS,-0.33,0
1,-2.8,C0009241,M1,1,0,DisGeNET,35,Cognition Disorders,,-2.8,3.4,3.9,30286,606,134,9,6.7,2.2,367|7337|7534|9037|10846|29978|91851|93986|388015,AR|UBE3A|YWHAZ|SEMA5A|PDE10A|UBQLN2|CHRDL1|FOXP2|RTL1,-0.33,0
1,-2.8,C0024305,M1,1,0,DisGeNET,35,"Lymphoma, Non-Hodgkin",,-2.8,3.1,3.8,30286,733,134,10,7.5,2.3,367|808|2321|2857|3567|4869|5000|9963|10803|27306,AR|CALM3|FLT1|GPR34|IL5|NPM1|ORC4|SLC23A1|CCR9|HPGDS,-0.31,0
1,-2.8,C1336905,M1,1,0,DisGeNET,35,Endometrial Endometrioid Adenocarcinoma,,-2.8,13,5.7,30286,53,134,3,2.2,1.3,285|367|1540,ANGPT2|AR|CYLD,-0.3,0
1,-2.8,C1384666,M1,1,0,DisGeNET,35,hearing impairment,,-2.8,3.1,3.8,30286,739,134,10,7.5,2.3,71|443|1687|2263|3769|4747|4907|4998|5000|27306,ACTG1|ASPA|GSDME|FGFR2|KCNJ13|NEFL|NT5E|ORC1|ORC4|HPGDS,-0.3,0
1,-2.8,C4086152,M1,1,0,DisGeNET,35,Childhood Astrocytoma,,-2.8,3.3,3.9,30286,615,134,9,6.7,2.2,285|4747|4869|5354|7010|7534|8452|27306|64805,ANGPT2|NEFL|NPM1|PLP1|TEK|YWHAZ|CUL3|HPGDS|P2RY12,-0.3,0
1,-2.7,C0733682,M1,1,0,DisGeNET,35,"Hypophosphatemic Rickets, X-Linked Dominant",,-2.7,13,5.7,30286,54,134,3,2.2,1.3,367|2742|4907,AR|GLRA2|NT5E,-0.29,0
1,-2.7,C1827293,M1,1,0,DisGeNET,35,"Carcinoma of urinary bladder, invasive",,-2.7,4.7,4.2,30286,287,134,6,4.5,1.8,367|2321|7534|8633|9122|27306,AR|FLT1|YWHAZ|UNC5C|SLC16A4|HPGDS,-0.29,0
1,-2.7,C0085109,M1,1,0,DisGeNET,35,Corneal Neovascularization,,-2.7,7.7,4.9,30286,117,134,4,3,1.5,285|2321|7010|9068,ANGPT2|FLT1|TEK|ANGPTL1,-0.28,0
1,-2.7,C0015625,M1,1,0,DisGeNET,35,Fanconi Anemia,,-2.7,4,4,30286,393,134,7,5.2,1.9,52|367|4809|4869|4988|7150|27306,ACP1|AR|SNU13|NPM1|OPRM1|TOP1|HPGDS,-0.28,0
1,-2.7,C0007114,M1,1,0,DisGeNET,35,Malignant neoplasm of skin,,-2.7,3.6,3.9,30286,507,134,8,6,2,71|367|808|1540|2263|2321|3858|27306,ACTG1|AR|CALM3|CYLD|FGFR2|FLT1|KRT10|HPGDS,-0.28,0
1,-2.7,C0276447,M1,1,0,DisGeNET,35,Rhinovirus infection,,-2.7,5.6,4.4,30286,202,134,5,3.7,1.6,3184|3567|4907|5094|27306,HNRNPD|IL5|NT5E|PCBP2|HPGDS,-0.25,0
1,-2.7,C0270736,M1,1,0,DisGeNET,35,Essential Tremor,,-2.7,7.4,4.7,30286,122,134,4,3,1.5,808|27306|27429|29119,CALM3|HPGDS|HTRA2|CTNNA3,-0.25,0
1,-2.7,C0013080,M1,1,0,DisGeNET,35,Down Syndrome,,-2.7,3,3.7,30286,765,134,10,7.5,2.3,443|2321|4747|4869|4907|7314|7337|23452|27306|388015,ASPA|FLT1|NEFL|NPM1|NT5E|UBB|UBE3A|ANGPTL2|HPGDS|RTL1,-0.24,0
1,-2.6,C4025272,M1,1,0,DisGeNET,35,Peripheral arterial stenosis,,-2.6,7.3,4.7,30286,124,134,4,3,1.5,285|367|2246|64805,ANGPT2|AR|FGF1|P2RY12,-0.23,0
1,-2.6,C0030486,M1,1,0,DisGeNET,35,Paraplegia,,-2.6,11,5.4,30286,59,134,3,2.2,1.3,367|5354|23767,AR|PLP1|FLRT3,-0.23,0
1,-2.6,C0270921,M1,1,0,DisGeNET,35,Axonal neuropathy,,-2.6,11,5.4,30286,59,134,3,2.2,1.3,4747|5354|7150,NEFL|PLP1|TOP1,-0.23,0
1,-2.6,C0020302,M1,1,0,DisGeNET,35,Hydrophthalmos,,-2.6,11,5.3,30286,60,134,3,2.2,1.3,367|2263|7010,AR|FGFR2|TEK,-0.23,0
1,-2.6,C0024537,M1,1,0,DisGeNET,35,"Malaria, Vivax",,-2.6,11,5.3,30286,60,134,3,2.2,1.3,71|285|27306,ACTG1|ANGPT2|HPGDS,-0.23,0
1,-2.6,C0162835,M1,1,0,DisGeNET,35,Hypopigmentation disorder,,-2.6,7.2,4.6,30286,126,134,4,3,1.5,7337|23682|283652|388015,UBE3A|RAB38|SLC24A5|RTL1,-0.23,0
1,-2.6,C0021831,M1,1,0,DisGeNET,35,Intestinal Diseases,,-2.6,5.4,4.3,30286,209,134,5,3.7,1.6,3567|4988|9122|27306|93986,IL5|OPRM1|SLC16A4|HPGDS|FOXP2,-0.23,0
1,-2.6,C0270824,M1,1,0,DisGeNET,35,Visual seizure,,-2.6,5.4,4.3,30286,209,134,5,3.7,1.6,4988|5354|7529|7534|57142,OPRM1|PLP1|YWHAB|YWHAZ|RTN4,-0.23,0
1,-2.6,C1153706,M1,1,0,DisGeNET,35,Endometrial adenocarcinoma,,-2.6,5.3,4.2,30286,212,134,5,3.7,1.6,367|1540|2263|5734|9122,AR|CYLD|FGFR2|PTGER4|SLC16A4,-0.21,0
1,-2.6,C0340076,M1,1,0,DisGeNET,35,Asthmatic pulmonary eosinophilia,,-2.6,11,5.2,30286,62,134,3,2.2,1.3,3567|10758|64805,IL5|TRAF3IP2|P2RY12,-0.21,0
1,-2.6,C1847514,M1,1,0,DisGeNET,35,Postnatal microcephaly,,-2.6,11,5.2,30286,62,134,3,2.2,1.3,71|7337|27429,ACTG1|UBE3A|HTRA2,-0.21,0
1,-2.6,C2733158,M1,1,0,DisGeNET,35,Cerebral Small Vessel Diseases,,-2.6,11,5.2,30286,62,134,3,2.2,1.3,285|3769|4747,ANGPT2|KCNJ13|NEFL,-0.21,0
1,-2.6,C0014599,M1,1,0,DisGeNET,35,Epithelial hyperplasia,,-2.6,11,5.2,30286,63,134,3,2.2,1.3,3567|7337|55840,IL5|UBE3A|EAF2,-0.2,0
1,-2.6,C0156394,M1,1,0,DisGeNET,35,Hypertrophy of clitoris,,-2.6,11,5.2,30286,63,134,3,2.2,1.3,2263|4998|5000,FGFR2|ORC1|ORC4,-0.2,0
1,-2.5,C2350236,M1,1,0,DisGeNET,35,Idiopathic Interstitial Pneumonias,,-2.5,11,5.1,30286,64,134,3,2.2,1.3,285|3184|5094,ANGPT2|HNRNPD|PCBP2,-0.18,0
1,-2.5,C4552766,M1,1,0,DisGeNET,35,Miscarriage,,-2.5,3.7,3.8,30286,426,134,7,5.2,1.9,285|1540|2263|2321|4907|23767|27306,ANGPT2|CYLD|FGFR2|FLT1|NT5E|FLRT3|HPGDS,-0.18,0
1,-2.5,C4521042,M1,1,0,DisGeNET,35,Complete Trisomy 21 Syndrome,,-2.5,3,3.6,30286,668,134,9,6.7,2.2,443|2321|4747|4869|4907|7314|7337|23452|27306,ASPA|FLT1|NEFL|NPM1|NT5E|UBB|UBE3A|ANGPTL2|HPGDS,-0.18,0
1,-2.5,C0878773,M1,1,0,DisGeNET,35,Overactive Bladder,,-2.5,10,5.1,30286,65,134,3,2.2,1.3,4747|7010|64805,NEFL|TEK|P2RY12,-0.18,0
1,-2.5,C4551689,M1,1,0,DisGeNET,35,Sleep-Disordered Breathing,,-2.5,10,5.1,30286,65,134,3,2.2,1.3,71|367|4747,ACTG1|AR|NEFL,-0.18,0
1,-2.5,C0010709,M1,1,0,DisGeNET,35,Cyst,,-2.5,5.1,4.1,30286,221,134,5,3.7,1.6,285|367|2321|3567|4907,ANGPT2|AR|FLT1|IL5|NT5E,-0.17,0
1,-2.5,C0035222,M1,1,0,DisGeNET,35,"Respiratory Distress Syndrome, Adult",,-2.5,3.6,3.7,30286,434,134,7,5.2,1.9,285|4907|4988|7010|7534|23452|27306,ANGPT2|NT5E|OPRM1|TEK|YWHAZ|ANGPTL2|HPGDS,-0.15,0
1,-2.5,C4721806,M1,1,0,DisGeNET,35,"Carcinoma, Basal Cell",,-2.5,3.2,3.6,30286,557,134,8,6,2,367|1540|2263|2321|4907|7010|27306|128344,AR|CYLD|FGFR2|FLT1|NT5E|TEK|HPGDS|CIMAP3,-0.13,0
1,-2.5,C0007758,M1,1,0,DisGeNET,35,Cerebellar Ataxia,,-2.5,3.6,3.7,30286,440,134,7,5.2,1.9,212|367|808|4747|7150|7337|552889,ALAS2|AR|CALM3|NEFL|TOP1|UBE3A|ATXN7L3B,-0.12,0
1,-2.4,C1842083,M1,1,0,DisGeNET,35,Abnormality of the ribs,,-2.4,9.8,4.9,30286,69,134,3,2.2,1.3,2263|4998|5000,FGFR2|ORC1|ORC4,-0.12,0
1,-2.4,C0282612,M1,1,0,DisGeNET,35,Prostatic Intraepithelial Neoplasias,,-2.4,4.9,4,30286,230,134,5,3.7,1.6,367|2321|4747|27306|55840,AR|FLT1|NEFL|HPGDS|EAF2,-0.12,0
1,-2.4,C0085281,M1,1,0,DisGeNET,35,Addictive Behavior,,-2.4,4.1,3.8,30286,332,134,6,4.5,1.8,367|808|2263|3567|4988|9122,AR|CALM3|FGFR2|IL5|OPRM1|SLC16A4,-0.12,0
1,-2.4,C3900098,M1,1,0,DisGeNET,35,Adult Myelodysplastic Syndrome,,-2.4,4.1,3.8,30286,332,134,6,4.5,1.8,285|367|2321|4869|27306|79184,ANGPT2|AR|FLT1|NPM1|HPGDS|BRCC3,-0.12,0
1,-2.4,C0034068,M1,1,0,DisGeNET,35,Pulmonary Eosinophilia,,-2.4,9.7,4.9,30286,70,134,3,2.2,1.3,3567|10758|64805,IL5|TRAF3IP2|P2RY12,-0.12,0
1,-2.4,C0017168,M1,1,0,DisGeNET,35,Gastroesophageal reflux disease,,-2.4,3.5,3.6,30286,446,134,7,5.2,1.9,443|1540|2321|4907|4998|5000|93986,ASPA|CYLD|FLT1|NT5E|ORC1|ORC4|FOXP2,-0.11,0
1,-2.4,C0018133,M1,1,0,DisGeNET,35,Graft-vs-Host Disease,,-2.4,3.5,3.6,30286,447,134,7,5.2,1.9,285|3567|4869|4907|4988|10803|388015,ANGPT2|IL5|NPM1|NT5E|OPRM1|CCR9|RTL1,-0.11,0
1,-2.4,C2347761,M1,1,0,DisGeNET,35,Childhood Myelodysplastic Syndrome,,-2.4,4,3.7,30286,335,134,6,4.5,1.8,285|367|2321|4869|27306|79184,ANGPT2|AR|FLT1|NPM1|HPGDS|BRCC3,-0.11,0
1,-2.4,C0037772,M1,1,0,DisGeNET,35,Spastic Paraplegia,,-2.4,6.3,4.2,30286,144,134,4,3,1.5,808|5354|29978|57531,CALM3|PLP1|UBQLN2|HACE1,-0.11,0
1,-2.4,C0376634,M1,1,0,DisGeNET,35,Craniofacial Abnormalities,,-2.4,4.8,3.9,30286,234,134,5,3.7,1.6,71|658|2263|7337|93986,ACTG1|BMPR1B|FGFR2|UBE3A|FOXP2,-0.11,0
1,-2.4,C0151650,M1,1,0,DisGeNET,35,Renal fibrosis,,-2.4,3.2,3.5,30286,570,134,8,6,2,285|367|2263|4907|6019|8452|23452|27306,ANGPT2|AR|FGFR2|NT5E|RLN2|CUL3|ANGPTL2|HPGDS,-0.11,0
1,-2.4,C0003872,M1,1,0,DisGeNET,35,"Arthritis, Psoriatic",,-2.4,3.5,3.6,30286,450,134,7,5.2,1.9,285|443|3151|7010|10758|23741|29119,ANGPT2|ASPA|HMGN2|TEK|TRAF3IP2|EID1|CTNNA3,-0.11,0
1,-2.4,C1333015,M1,1,0,DisGeNET,35,Childhood Kidney Wilms Tumor,,-2.4,4,3.7,30286,338,134,6,4.5,1.8,367|4747|4869|26136|29119|57531,AR|NEFL|NPM1|TES|CTNNA3|HACE1,-0.11,0
1,-2.4,C0278488,M1,1,0,DisGeNET,35,Carcinoma breast stage IV,,-2.4,3.2,3.5,30286,573,134,8,6,2,71|285|367|2263|4907|7150|9122|27306,ACTG1|ANGPT2|AR|FGFR2|NT5E|TOP1|SLC16A4|HPGDS,-0.11,0
1,-2.4,C0013421,M1,1,0,DisGeNET,35,Dystonia,,-2.4,3.5,3.6,30286,453,134,7,5.2,1.9,4988|5354|10846|27429|29978|57531|124512,OPRM1|PLP1|PDE10A|HTRA2|UBQLN2|HACE1|METTL23,-0.1,0
1,-2.4,C0029927,M1,1,0,DisGeNET,35,Ovarian Cysts,,-2.4,9.2,4.7,30286,74,134,3,2.2,1.3,2321|2857|5734,FLT1|GPR34|PTGER4,-0.089,0
1,-2.4,C0026838,M1,1,0,DisGeNET,35,Muscle Spasticity,,-2.4,3.1,3.4,30286,580,134,8,6,2,367|443|4747|4988|5354|27429|29978|124512,AR|ASPA|NEFL|OPRM1|PLP1|HTRA2|UBQLN2|METTL23,-0.089,0
1,-2.4,C0314719,M1,1,0,DisGeNET,35,Dryness of eye,,-2.4,6.1,4.1,30286,149,134,4,3,1.5,367|3567|27306|79184,AR|IL5|HPGDS|BRCC3,-0.089,0
1,-2.3,C3665444,M1,1,0,DisGeNET,35,Neutrophilia (disorder),,-2.3,6,4.1,30286,150,134,4,3,1.5,367|3567|7010|10758,AR|IL5|TEK|TRAF3IP2,-0.082,0
1,-2.3,C0001175,M1,1,0,DisGeNET,35,Acquired Immunodeficiency Syndrome,,-2.3,4.7,3.8,30286,243,134,5,3.7,1.6,367|2246|3567|4988|23452,AR|FGF1|IL5|OPRM1|ANGPTL2,-0.08,0
1,-2.3,C0334533,M1,1,0,DisGeNET,35,Arteriovenous hemangioma,,-2.3,8.9,4.6,30286,76,134,3,2.2,1.3,285|2321|7010,ANGPT2|FLT1|TEK,-0.073,0
1,-2.3,C0302142,M1,1,0,DisGeNET,35,Deformity,,-2.3,3.9,3.6,30286,350,134,6,4.5,1.8,71|285|658|2263|5354|7010,ACTG1|ANGPT2|BMPR1B|FGFR2|PLP1|TEK,-0.071,0
1,-2.3,C0574785,M1,1,0,DisGeNET,35,Lower Urinary Tract Symptoms,,-2.3,8.8,4.6,30286,77,134,3,2.2,1.3,367|2263|64805,AR|FGFR2|P2RY12,-0.062,0
1,-2.3,C1510472,M1,1,0,DisGeNET,35,Drug Dependence,,-2.3,4.6,3.7,30286,248,134,5,3.7,1.6,367|4869|4988|27306|29119,AR|NPM1|OPRM1|HPGDS|CTNNA3,-0.058,0
1,-2.3,C1868684,M1,1,0,DisGeNET,35,"EAR, PATELLA, SHORT STATURE SYNDROME",,-2.3,8.7,4.5,30286,78,134,3,2.2,1.3,71|4998|5000,ACTG1|ORC1|ORC4,-0.058,0
1,-2.3,C0087012,M1,1,0,DisGeNET,35,"Ataxia, Spinocerebellar",,-2.3,5.8,4,30286,155,134,4,3,1.5,212|367|4747|7150,ALAS2|AR|NEFL|TOP1,-0.058,0
1,-2.3,C4733092,M1,1,0,DisGeNET,35,estrogen receptor-negative breast cancer,,-2.3,3.8,3.6,30286,356,134,6,4.5,1.8,285|367|2246|2263|2321|3326,ANGPT2|AR|FGF1|FGFR2|FLT1|HSP90AB1,-0.058,0
1,-2.3,C0013238,M1,1,0,DisGeNET,35,Dry Eye Syndromes,,-2.3,5.8,4,30286,156,134,4,3,1.5,367|3567|27306|79184,AR|IL5|HPGDS|BRCC3,-0.058,0
1,-2.3,C0042025,M1,1,0,DisGeNET,35,Urinary Stress Incontinence,,-2.3,8.6,4.5,30286,79,134,3,2.2,1.3,71|367|10209,ACTG1|AR|EIF1,-0.058,0
1,-2.3,C0000772,M1,1,0,DisGeNET,35,Multiple congenital anomalies,,-2.3,4.5,3.7,30286,251,134,5,3.7,1.6,71|2263|5354|8452|124512,ACTG1|FGFR2|PLP1|CUL3|METTL23,-0.058,0
1,-2.3,C0015230,M1,1,0,DisGeNET,35,Exanthema,,-2.3,4.5,3.7,30286,251,134,5,3.7,1.6,367|3567|7010|10758|27306,AR|IL5|TEK|TRAF3IP2|HPGDS,-0.058,0
1,-2.3,C0271084,M1,1,0,DisGeNET,35,Exudative age-related macular degeneration,,-2.3,5.7,4,30286,158,134,4,3,1.5,285|2321|7010|27306,ANGPT2|FLT1|TEK|HPGDS,-0.053,0
1,-2.3,C0151811,M1,1,0,DisGeNET,35,Subcutaneous nodule,,-2.3,8.5,4.5,30286,80,134,3,2.2,1.3,1540|2263|7010,CYLD|FGFR2|TEK,-0.053,0
1,-2.3,C1737329,M1,1,0,DisGeNET,35,Dysmorphism,,-2.3,8.5,4.5,30286,80,134,3,2.2,1.3,367|2263|93986,AR|FGFR2|FOXP2,-0.053,0
1,-2.3,C0026650,M1,1,0,DisGeNET,35,Movement Disorders,,-2.3,3.7,3.5,30286,362,134,6,4.5,1.8,4988|7337|7534|10846|27429|93986,OPRM1|UBE3A|YWHAZ|PDE10A|HTRA2|FOXP2,-0.047,0
1,-2.2,C0520679,M1,1,0,DisGeNET,35,"Sleep Apnea, Obstructive",,-2.2,3.3,3.4,30286,480,134,7,5.2,1.9,226|285|367|808|4907|4988|7010,ALDOA|ANGPT2|AR|CALM3|NT5E|OPRM1|TEK,-0.047,0
1,-2.2,C0037286,M1,1,0,DisGeNET,35,Skin Neoplasms,,-2.2,3.7,3.5,30286,363,134,6,4.5,1.8,1540|2263|2321|3858|4869|27306,CYLD|FGFR2|FLT1|KRT10|NPM1|HPGDS,-0.047,0
1,-2.2,C0220615,M1,1,0,DisGeNET,35,Adult Acute Myeloblastic Leukemia,,-2.2,5.7,3.9,30286,160,134,4,3,1.5,808|2321|4869|27306,CALM3|FLT1|NPM1|HPGDS,-0.047,0
1,-2.2,C0027022,M1,1,0,DisGeNET,35,Myeloproliferative disease,,-2.2,3.7,3.5,30286,365,134,6,4.5,1.8,367|2321|3567|4067|4869|7010,AR|FLT1|IL5|LYN|NPM1|TEK,-0.042,0
1,-2.2,C0009763,M1,1,0,DisGeNET,35,Conjunctivitis,,-2.2,8.3,4.4,30286,82,134,3,2.2,1.3,2263|7010|196294,FGFR2|TEK|IMMP1L,-0.042,0
1,-2.2,C0027430,M1,1,0,DisGeNET,35,Nasal Polyps,,-2.2,3.3,3.4,30286,484,134,7,5.2,1.9,71|285|2246|3567|7534|10758|27306,ACTG1|ANGPT2|FGF1|IL5|YWHAZ|TRAF3IP2|HPGDS,-0.039,0
1,-2.2,C0079772,M1,1,0,DisGeNET,35,T-Cell Lymphoma,,-2.2,3.3,3.3,30286,485,134,7,5.2,1.9,367|3326|3567|4869|4988|10803|57531,AR|HSP90AB1|IL5|NPM1|OPRM1|CCR9|HACE1,-0.037,0
1,-2.2,C3469186,M1,1,0,DisGeNET,35,"HEMOCHROMATOSIS, TYPE 1",,-2.2,8.2,4.4,30286,83,134,3,2.2,1.3,1540|27306|55840,CYLD|HPGDS|EAF2,-0.036,0
1,-2.2,C0162298,M1,1,0,DisGeNET,35,Joint stiffness,,-2.2,5.5,3.9,30286,163,134,4,3,1.5,71|658|2263|4907,ACTG1|BMPR1B|FGFR2|NT5E,-0.036,0
1,-2.2,C0013362,M1,1,0,DisGeNET,35,Dysarthria,,-2.2,3.2,3.3,30286,487,134,7,5.2,1.9,367|5354|10846|23767|29978|57531|93986,AR|PLP1|PDE10A|FLRT3|UBQLN2|HACE1|FOXP2,-0.036,0
1,-2.2,C0020443,M1,1,0,DisGeNET,35,Hypercholesterolemia,,-2.2,3.2,3.3,30286,489,134,7,5.2,1.9,367|2321|4907|6613|7534|27306|27329,AR|FLT1|NT5E|SUMO2|YWHAZ|HPGDS|ANGPTL3,-0.036,0
1,-2.2,C0079218,M1,1,0,DisGeNET,35,"Fibromatosis, Aggressive",,-2.2,8.1,4.3,30286,84,134,3,2.2,1.3,367|4067|29119,AR|LYN|CTNNA3,-0.036,0
1,-2.2,C1857108,M1,1,0,DisGeNET,35,Limitation of joint mobility,,-2.2,8.1,4.3,30286,84,134,3,2.2,1.3,658|2263|5354,BMPR1B|FGFR2|PLP1,-0.036,0
1,-2.2,C1854494,M1,1,0,DisGeNET,35,Slow progression,,-2.2,5.5,3.8,30286,165,134,4,3,1.5,367|4747|5354|203547,AR|NEFL|PLP1|VMA21,-0.036,0
1,-2.2,C4025790,M1,1,0,DisGeNET,35,Specific learning disability,,-2.2,5.5,3.8,30286,165,134,4,3,1.5,71|4998|5000|93986,ACTG1|ORC1|ORC4|FOXP2,-0.036,0
1,-2.2,C0014869,M1,1,0,DisGeNET,35,Peptic Esophagitis,,-2.2,8,4.3,30286,85,134,3,2.2,1.3,1540|3567|27306,CYLD|IL5|HPGDS,-0.033,0
1,-2.2,C1997217,M1,1,0,DisGeNET,35,Low grade glioma,,-2.2,8,4.3,30286,85,134,3,2.2,1.3,367|2321|26292,AR|FLT1|MYCBP,-0.033,0
1,-2.2,C0242422,M1,1,0,DisGeNET,35,Parkinsonian Disorders,,-2.2,3.6,3.4,30286,373,134,6,4.5,1.8,4067|4747|7534|10846|27306|27429,LYN|NEFL|YWHAZ|PDE10A|HPGDS|HTRA2,-0.033,0
1,-2.2,C0007138,M1,1,0,DisGeNET,35,"Carcinoma, Transitional Cell",,-2.2,2.9,3.2,30286,622,134,8,6,2,285|367|2263|2321|9122|27306|29119|29978,ANGPT2|AR|FGFR2|FLT1|SLC16A4|HPGDS|CTNNA3|UBQLN2,-0.028,0
1,-2.2,C0162809,M1,1,0,DisGeNET,35,Kallmann Syndrome,,-2.2,7.9,4.3,30286,86,134,3,2.2,1.3,2246|4907|23767,FGF1|NT5E|FLRT3,-0.028,0
1,-2.2,C0220656,M1,1,0,DisGeNET,35,Malignant ascites,,-2.2,7.9,4.3,30286,86,134,3,2.2,1.3,2263|7010|9122,FGFR2|TEK|SLC16A4,-0.028,0
1,-2.2,C4021611,M1,1,0,DisGeNET,35,Abnormality of epiphysis morphology,,-2.2,7.9,4.3,30286,86,134,3,2.2,1.3,658|4998|5000,BMPR1B|ORC1|ORC4,-0.028,0
1,-2.2,C0008626,M1,1,0,DisGeNET,35,Congenital chromosomal disease,,-2.2,2.7,3.1,30286,757,134,9,6.7,2.2,52|367|808|2321|3567|4869|4988|27306|388015,ACP1|AR|CALM3|FLT1|IL5|NPM1|OPRM1|HPGDS|RTL1,-0.028,0
1,-2.2,C0005779,M1,1,0,DisGeNET,35,Blood Coagulation Disorders,,-2.2,4.2,3.5,30286,266,134,5,3.7,1.6,71|285|367|2263|64805,ACTG1|ANGPT2|AR|FGFR2|P2RY12,-0.028,0
1,-2.2,C0234251,M1,1,0,DisGeNET,35,Inflammatory pain,,-2.2,4.2,3.5,30286,266,134,5,3.7,1.6,4988|5734|27306|64805|388015,OPRM1|PTGER4|HPGDS|P2RY12|RTL1,-0.028,0
1,-2.2,C0007095,M1,1,0,DisGeNET,35,Carcinoid Tumor,,-2.2,4.2,3.5,30286,267,134,5,3.7,1.6,3357|23682|26292|27306|57142,HTR2B|RAB38|MYCBP|HPGDS|RTN4,-0.025,0
1,-2.2,C1861172,M1,1,0,DisGeNET,35,Venous Thromboembolism,,-2.2,3.6,3.4,30286,378,134,6,4.5,1.8,285|4907|7534|55840|64805|79184,ANGPT2|NT5E|YWHAZ|EAF2|P2RY12|BRCC3,-0.025,0
1,-2.1,C0018553,M1,1,0,DisGeNET,35,"Hamartoma Syndrome, Multiple",,-2.1,4.2,3.5,30286,270,134,5,3.7,1.6,367|2263|9122|10803|64805,AR|FGFR2|SLC16A4|CCR9|P2RY12,-0.015,0
1,-2.1,C3875321,M1,1,0,DisGeNET,35,Inflammatory dermatosis,,-2.1,3.5,3.3,30286,382,134,6,4.5,1.8,2263|3567|3858|7010|10758|27306,FGFR2|IL5|KRT10|TEK|TRAF3IP2|HPGDS,-0.012,0
1,-2.1,C0025362,M1,1,0,DisGeNET,35,Mental Retardation,,-2.1,3.1,3.2,30286,504,134,7,5.2,1.9,367|2321|3187|4747|7337|9037|93986,AR|FLT1|HNRNPH1|NEFL|UBE3A|SEMA5A|FOXP2,-0.012,0
1,-2.1,C0578870,M1,1,0,DisGeNET,35,Chronic idiopathic urticaria,,-2.1,7.6,4.2,30286,89,134,3,2.2,1.3,71|3567|27306,ACTG1|IL5|HPGDS,-0.012,0
1,-2.1,C1176475,M1,1,0,DisGeNET,35,Ductal Carcinoma,,-2.1,4.1,3.5,30286,273,134,5,3.7,1.6,226|285|367|2321|27306,ALDOA|ANGPT2|AR|FLT1|HPGDS,-0.0073,0
1,-2.1,C0494463,M1,1,0,DisGeNET,35,"Alzheimer Disease, Late Onset",,-2.1,3.5,3.3,30286,385,134,6,4.5,1.8,71|808|8633|27306|27328|29119,ACTG1|CALM3|UNC5C|HPGDS|PCDH11X|CTNNA3,-0.0073,0
1,-2.1,C0917801,M1,1,0,DisGeNET,35,Sleeplessness,,-2.1,5.2,3.7,30286,174,134,4,3,1.5,71|367|4988|27429,ACTG1|AR|OPRM1|HTRA2,-0.0047,0
1,-2.1,C0278595,M1,1,0,DisGeNET,35,Adult Fibrosarcoma,,-2.1,3.5,3.3,30286,387,134,6,4.5,1.8,2246|2321|7010|7150|9068|388015,FGF1|FLT1|TEK|TOP1|ANGPTL1|RTL1,-0.0021,0
1,-2.1,C4290046,M1,1,0,DisGeNET,35,trachomatis,,-2.1,5.2,3.7,30286,175,134,4,3,1.5,71|2321|3567|27306,ACTG1|FLT1|IL5|HPGDS,-0.0014,0
1,-2.1,C0021125,M1,1,0,DisGeNET,35,Impulsive Behavior,,-2.1,4.1,3.4,30286,276,134,5,3.7,1.6,367|3357|4988|27429|124512,AR|HTR2B|OPRM1|HTRA2|METTL23,-0.00068,0
1,-2.1,C0011168,M1,1,0,DisGeNET,35,Deglutition Disorders,,-2.1,3.5,3.3,30286,389,134,6,4.5,1.8,367|443|3567|4907|5354|29978,AR|ASPA|IL5|NT5E|PLP1|UBQLN2,-0.00045,0
1,-2.1,C0153690,M1,1,0,DisGeNET,35,Secondary malignant neoplasm of bone,,-2.1,2.8,3.1,30286,647,134,8,6,2,285|367|2263|2321|7010|9122|9358|23452,ANGPT2|AR|FGFR2|FLT1|TEK|SLC16A4|ITGBL1|ANGPTL2,0,0
1,-2.1,C4511452,M1,1,0,DisGeNET,35,Sporadic Parkinson disease,,-2.1,5.1,3.6,30286,179,134,4,3,1.5,9037|10846|27306|27429,SEMA5A|PDE10A|HPGDS|HTRA2,0,0
1,-2.1,C3553764,M1,1,0,DisGeNET,35,Joint hyperflexibility,,-2.1,5,3.6,30286,181,134,4,3,1.5,4998|5000|7337|9037,ORC1|ORC4|UBE3A|SEMA5A,0,0
1,-2.1,C0013132,M1,1,0,DisGeNET,35,Drooling,,-2.1,7.1,4,30286,95,134,3,2.2,1.3,7337|10846|93986,UBE3A|PDE10A|FOXP2,0,0
1,-2.1,C0152020,M1,1,0,DisGeNET,35,Gastroparesis,,-2.1,7.1,4,30286,95,134,3,2.2,1.3,4988|10803|27429,OPRM1|CCR9|HTRA2,0,0
1,-2.1,C0206708,M1,1,0,DisGeNET,35,Cervical Intraepithelial Neoplasia,,-2.1,3.4,3.2,30286,398,134,6,4.5,1.8,367|2263|4907|7337|23452|27306,AR|FGFR2|NT5E|UBE3A|ANGPTL2|HPGDS,0,0
1,-2.1,C1850049,M1,1,0,DisGeNET,35,Clinodactyly of the 5th finger,,-2.1,4,3.4,30286,284,134,5,3.7,1.6,658|2263|4998|5000|7337,BMPR1B|FGFR2|ORC1|ORC4|UBE3A,0,0
1,-2.1,C0206695,M1,1,0,DisGeNET,35,"Carcinoma, Neuroendocrine",,-2.1,5,3.6,30286,182,134,4,3,1.5,367|3567|4907|5734,AR|IL5|NT5E|PTGER4,0,0
1,-2.1,C0265219,M1,1,0,DisGeNET,35,Miller Dieker syndrome,,-2.1,5,3.6,30286,182,134,4,3,1.5,2246|2321|4869|7337,FGF1|FLT1|NPM1|UBE3A,0,0
1,-2.1,C0752304,M1,1,0,DisGeNET,35,Hypoxic-Ischemic Encephalopathy,,-2.1,5,3.6,30286,182,134,4,3,1.5,2246|3769|4747|7010,FGF1|KCNJ13|NEFL|TEK,0,0
1,-2,C0003130,M1,1,0,DisGeNET,35,Anoxia,,-2,3.9,3.3,30286,287,134,5,3.7,1.6,285|367|2321|7010|9122,ANGPT2|AR|FLT1|TEK|SLC16A4,0,0
1,-2,C0032897,M1,1,0,DisGeNET,35,Prader-Willi Syndrome,,-2,4.9,3.5,30286,184,134,4,3,1.5,367|3357|7337|23741,AR|HTR2B|UBE3A|EID1,0,0
1,-2,C0040822,M1,1,0,DisGeNET,35,Tremor,,-2,3,3.1,30286,528,134,7,5.2,1.9,367|443|5354|7534|10846|23767|27429,AR|ASPA|PLP1|YWHAZ|PDE10A|FLRT3|HTRA2,0,0
1,-2,C0026277,M1,1,0,DisGeNET,35,Mixed Salivary Gland Tumor,,-2,4.9,3.5,30286,185,134,4,3,1.5,367|2263|2321|27306,AR|FGFR2|FLT1|HPGDS,0,0
1,-2,C0852036,M1,1,0,DisGeNET,35,Pregnancy associated hypertension,,-2,4.9,3.5,30286,186,134,4,3,1.5,71|2321|7534|27306,ACTG1|FLT1|YWHAZ|HPGDS,0,0
1,-2,C0740457,M1,1,0,DisGeNET,35,Malignant neoplasm of kidney,,-2,2.7,3,30286,664,134,8,6,2,367|808|2321|4907|8633|9122|27306|91851,AR|CALM3|FLT1|NT5E|UNC5C|SLC16A4|HPGDS|CHRDL1,0,0
1,-2,C2316810,M1,1,0,DisGeNET,35,Chronic kidney disease stage 5,,-2,2.7,3,30286,666,134,8,6,2,285|2321|5354|5734|7534|27306|64805|283652,ANGPT2|FLT1|PLP1|PTGER4|YWHAZ|HPGDS|P2RY12|SLC24A5,0,0
1,-2,C0042341,M1,1,0,DisGeNET,35,Varicocele,,-2,6.8,3.9,30286,99,134,3,2.2,1.3,52|367|27306,ACP1|AR|HPGDS,0,0
1,-2,C2936719,M1,1,0,DisGeNET,35,Mechanical Allodynia,,-2,3.3,3.2,30286,408,134,6,4.5,1.8,3357|4988|7534|23767|64805|388015,HTR2B|OPRM1|YWHAZ|FLRT3|P2RY12|RTL1,0,0
1,-2,C1535926,M1,1,0,DisGeNET,35,Neurodevelopmental Disorders,,-2,3,3.1,30286,534,134,7,5.2,1.9,7337|8452|10846|27306|57531|93986|347730,UBE3A|CUL3|PDE10A|HPGDS|HACE1|FOXP2|LRRTM1,0,0
1,-2,C0221505,M1,1,0,DisGeNET,35,Lesion of brain,,-2,4.8,3.5,30286,188,134,4,3,1.5,2321|4747|5354|55840,FLT1|NEFL|PLP1|EAF2,0,0
